Across TCGA pan-cancer cohorts, MTND3P21 RNA differs between tumor and matched normal tissue in 1 of 18 cancer types tested, making tumor–normal expression one of MTND3P21’s most consistent transcriptional readouts.

The strongest signal is observed in liver hepatocellular carcinoma (LIHC), where MTND3P21 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types MTND3P21 is over-expressed in tumor.

LIHC are the cancer types where MTND3P21 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in MTND3P21 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
LIHC	All	All	+0.025	.032	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 1 strongest of 1 lineages.

MTND3P21–LIHC

Tumor-vs-normal expression box plot for MTND3P21 RNA in LIHC.

Open the LIHC breakdown →

Exploration

Same gene, other analysis: MTND3P21 RNA expression & survival · all MTND3P21 data types